Tetrasubstituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines and method of reducing TNF.alpha. levels
US5798368A · kind A · utility
153Cited by
5References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 22, 1996 |
| Grant date | Aug 25, 1998 |
| Priority date | — |
| Expiry date | Aug 22, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Tetrasubstituted 1-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines reduce the levels of TNF.alpha. in a mammal. A typical embodiment is 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4,5,6,7-tetrafluoroisoindoline.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.